Results 121 to 130 of about 677,925 (163)

WEE1 kinase in cancer: Molecular mechanisms and inhibitor insights

EXCLI Journal; 25:Doc1186; ISSN 1611 ...
Kumar, Ankush, Paudel, Keshav Raj, Kaur, Rajwinder, Bhatia, Rohit   +3 more
openaire   +1 more source

The Clinical Landscape of HDAC Inhibitors

Medical Epigenetics, 2021
Arasu Ganesan
exaly  

Therapeutics and DNA Methylation Inhibitors

Medical Epigenetics, 2021
Shyamala C Navada
exaly  

ALLOSTERIC INHIBITOR OF WEE1 KINASE

2021
MAHAJAN NUPAM, LAWRENCE NICHOLAS
openaire   +2 more sources

WEE1 INHIBITOR FOR CANCER

2023
DONATE FERNANDO, IZADI HOOMAN, DE JONG PETRUS RUDOLF, SAMATAR AHMED ABDI, BUNKER KEVIN DUANE, HUANG PETER QINHUA   +5 more
openaire   +1 more source

WEE1 INHIBITORS AND METHODS FOR TREATING CANCER

2022
SAMATAR AHMED, DONATE FERNANDO, DE JONG PETRUS, ESCOUBET LAURE, LIU WEN, PULTAR PHILIPPE, VOLIOTIS DIMITRIOS, BUNKER KEVIN, HUANG PETER   +8 more
openaire   +4 more sources

Histone Deacetylase Inhibitors in Medical Therapeutics

Medical Epigenetics, 2021
exaly  

Inhibitors of Cell Cycle Checkpoint Target Wee1 Kinase – A Patent Review (2003–2022)

Expert Opinion on Therapeutic Patents, 2022
Yadong Chen, Yong Zhu, Zhenlin Tu
exaly  

Pyrimidopyrazolone derivative as Wee1 inhibitor and use thereof

2021
QIAN WENYUAN, YANG CHUNDAO, LI ZHENGWEI, LI JIAN, CHEN SHUHUI   +4 more
openaire   +2 more sources

Sequential Therapy With PARP and WEE1 Inhibitors Minimizes Toxicity While Maintaining Efficacy

Cancer Cell, 2019
Ken Chen, Zhenlin Ju, Gordon B. Mills
exaly